FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Implant, Anti-Gastroesophageal Reflux
PMA: P100049
·
Supplement: S024
·
Decision Oct 16, 2018
Classifications
1
FEI Numbers
2
Registration Numbers
2
Basic Information
- Device Name
- Implant, Anti-Gastroesophageal Reflux
- Trade Name
- LINX Reflux Management System
- PMA Number
- P100049
- Supplement Number
- S024
- Device Class
- FDA Class 3
- Product Code
- LEI
- Generic Name
- IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
- Medical Specialty
- Unknown
- Advisory Committee
- Gastroenterology, Urology
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- October 16, 2018
- Date Received
- September 19, 2018
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Implementation of changes to a manufacturing equipment.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LEI | Implant, Anti-Gastroesophageal Reflux | FDA class 3 | Unknown |